Senolytics in Senescent Cell Disease Trial

Testing the Body’s Own Pathways to Quiet Tinnitus

Nearly one in five adults experiences tinnitus, the perception of sound like ringing or buzzing without an external source. For many, it’s more than a nuisance; it’s linked to anxiety, sleep loss, and nervous system dysregulation. Drug therapies often disappoint, with limited relief and potential side effects. A new clinical trial in Taiwan is now testing two very different non-drug approaches: one targeting the foot, the other the ear. The study asks whether stimulating specific reflex points can reduce tinnitus by influencing the nervous system.

The Trial Design: Three Arms, Sham Controls, and Repeated Measures

Conducted at the Hualien Tzu Chi Hospital, this is a randomized, single-blind, sham-controlled trial. The “single-blind” designation means the assessors measuring outcomes do not know which treatment a participant received. Investigators will enroll 180 adults aged 18-75 who report tinnitus as their main concern and who have normal pure-tone hearing thresholds (≤25 dB HL).

Participants are first stratified by age and sex, then randomly assigned to one of three groups: a foot reflexology (FR) group, a transcutaneous auricular vagus nerve stimulation (ta-VNS) group, or a usual-care control group. The FR and ta-VNS groups are further split into “true” intervention and “sham” subgroups. This design allows researchers to distinguish between a therapy’s specific physiological effects and any benefits derived simply from attention or a treatment ritual.

What Participants Will Actually Do

For those in the active foot reflexology arm, the intervention consists of one 20-minute session per week for four weeks. A trained therapist performs a specific protocol: a relaxation phase, followed by focused stimulation of reflex points linked to the inner ear and autonomic regulation, and ending with a circulation phase. The sham version involves only light, non-specific touch on the foot.

In the active ta-VNS arm, participants receive stimulation on specific points of the left outer ear—the tragus, cymba conchae, and cavum conchae—using an electrical device. The stimulation parameters (a 250 µs pulse width at 25 Hz) are set to produce a gentle tingling sensation. Sessions also last 20 minutes, once a week for four weeks. The sham procedure applies a very low current to the left earlobe, an area not associated with vagus nerve stimulation. Additionally, all participants in the two intervention groups will self-administer auricular acupressure using magnetic beads on the ear three times daily.

Outcomes are tracked at four points: baseline, week 2, week 4, and week 8. The primary goal is to see if these interventions reduce tinnitus severity. Secondary measures include changes in anxiety, sleep quality, and two biomarkers of autonomic nervous system state: heart rate variability and levels of the stress hormone cortisol in saliva.

The Science Behind Stimulating Feet and Ears for Ear Symptoms

The rationale for this trial connects two distinct body systems to tinnitus pathology. Foot reflexology is based on the premise that specific points on the feet correspond to other organs and systems. Proponents suggest stimulating these points may influence nervous system function and promote relaxation, which could modulate the heightened neural activity believed to cause tinnitus perception.

Transcutaneous auricular vagus nerve stimulation has a more direct neuroscientific basis. The vagus nerve, a major component of the parasympathetic nervous system, has a branch that reaches the skin of the outer ear. Ta-VNS delivers gentle electrical pulses to activate this nerve branch. This activation is thought to send signals to brainstem and higher brain regions involved in auditory processing, emotional response, and autonomic control. By potentially calming an overactive sympathetic nervous system—often implicated in tinnitus distress—ta-VNS may lessen both the perception of tinnitus and its associated anxiety.

Trial Status and What It Means for Patients

The trial, registered under NCT07711639, is currently recruiting its target of 180 participants. Its completion and subsequent data analysis will take time.

If positive, the results could offer new directions for tinnitus management. The study does not just ask if symptoms improve; it seeks to understand how they might improve by tracking physiological stress markers. Demonstrating that either foot reflexology or ta-VNS can reliably alter both subjective distress and objective biomarkers would provide stronger evidence for integrating these approaches into clinical practice. For the many patients who find little relief from current options, this trial represents a structured investigation into alternative paths that target the body’s own regulatory systems.

This article is for informational purposes only. Consult a qualified professional for personalised advice.

Source:
FR-taVNS Tinnitus Tria (ClinicalTrials.gov: NCT07711639)